Fisher Alan
SEC insider (Form 3/4/5 filer). CIK 0002028654. Director at Neuphoria Therapeutics Inc. (NEUP). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 20, 2026. Located in BURLINGTON, MA.
Companies Fisher Alan has filed insider reports for
- Neuphoria Therapeutics Inc. (NEUP): Director
Fisher Alan
CIK: 0002028654
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NEUP
Neuphoria Therapeutics Inc.
Director